Penn Medicine - Penn Presbyterian Medical Center - Scheie Eye Institute — Philadelphia, Pennsylvania

Penn Medicine - Penn Presbyterian Medical Center - Scheie Eye Institute is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Penn Medicine - Penn Presbyterian Medical Center - Scheie Eye Institute has participated in 1 clinical trials.

Therapeutic areas: Thyroid Eye Disease.

Sponsors: argenx.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Philadelphia

Browse all research sites in Pennsylvania · View every site in Philadelphia

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Penn Medicine - Penn Presbyterian Medical Center - Scheie Eye Institute?

Penn Medicine - Penn Presbyterian Medical Center - Scheie Eye Institute has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Penn Medicine - Penn Presbyterian Medical Center - Scheie Eye Institute conducted?

Penn Medicine - Penn Presbyterian Medical Center - Scheie Eye Institute has 1 clinical trials on record. Their work covers Thyroid Eye Disease.

Is Penn Medicine - Penn Presbyterian Medical Center - Scheie Eye Institute accredited by Crixeo Clinical Trials?

Penn Medicine - Penn Presbyterian Medical Center - Scheie Eye Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Penn Medicine - Penn Presbyterian Medical Center - Scheie Eye Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.